SCHEMBL23911727

SCHEMBL23911727

O=P(c1ccccc1)(c1ccccc1)n1c2ccccc2c2cc(-n3c4ccccc4c4ccccc43)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.46
▸ ATM Q13315 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ NPSR1 Q6W5P4 3/20 0.38
▸ LMNA P02545 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ PTPN1 P18031 2/20 0.34
▸ EDNRB P24530 1/20 0.34
▸ EDNRA P25101 1/20 0.34
▸ HDAC4 P56524 1/20 0.33
▸ RAC2 P15153 1/20 0.32
▸ RAC3 P60763 1/20 0.32
▸ CDC42 P60953 1/20 0.32
▸ RAC1 P63000 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.32
▸ HPGD P15428 2/20 0.31
▸ MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911719 0.89 KDM4E (0.36) KDM4EATML3MBTL1NPSR1RAC2
SCHEMBL12792102 0.87 KDM4E (0.53) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL22146607 0.85 KDM4E (0.41) KDM4EATML3MBTL1NPSR1LMNA
SCHEMBL12792049 0.84 NPSR1 (0.40) KDM4EATML3MBTL1NPSR1LMNA
SCHEMBL23431347 0.83 NPSR1 (0.44) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL16447094 0.80 NPSR1 (0.42) KDM4EATML3MBTL1NPSR1LMNA
SCHEMBL18407466 0.79 KDM4E (0.51) KDM4EATML3MBTL1NPSR1LMNA
SCHEMBL21031983 0.79 KDM4E (0.38) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL24531917 0.78 L3MBTL1 (0.75) KDM4EATML3MBTL1ALDH1A1PTPN1
SCHEMBL21671314 0.78 L3MBTL1 (0.75) KDM4EATML3MBTL1ALDH1A1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-01-20 — — US disclosed
US-11145823-B2 Heterocyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145823-B2 Heterocyclic compound and organic light emitting device including the same TRPC1, ODC1, DDT KDM4E 1975/4885ATM 4697/4885L3MBTL1 138/4885
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC1, ODC1, DDT KDM4E 1600/4885ATM 4676/4885L3MBTL1 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback